Sandro Gelsomino, MD, PhD, Jos G

Slides:

Advertisements

Similar presentations

Surgical Versus Medical Therapy for Prosthetic Valve Endocarditis: A Meta-Analysis of 32 Studies Christos G. Mihos, DO, Romain Capoulade, PhD, Evin Yucel,

Advertisements

Mitral valve repair or replacement for ischemic mitral regurgitation

Leo M. Gazoni, MD, Lynn M. Fedoruk, MD, John A. Kern, MD, John M

Twenty-Five Year Experience With the St

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Mitral Valve Repair Without Repair of Moderate Tricuspid Regurgitation

John G. Byrne, MD, Katayoun Rezai, MD, Juan A

Reply The Annals of Thoracic Surgery

Constantin Stefanidis, MD, Albert M

Outcomes of Reintervention on the Autograft After Ross Procedure

Sreekumar Subramanian, MD, Sergey Leontyev, MD, Michael A

Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability? Tirone E. David, MD, Susan Armstrong, MS,

Aortic Valve Periprosthetic Leakage: Anatomic Observations and Surgical Results Giuseppe De Cicco, MD, Roberto Lorusso, MD, PhD, Andrea Colli, MD, Francesco.

Tetralogy of Fallot: surgical management individualized to the patient

Surgical Treatment of Culture-Negative Aortic Infective Endocarditis

Mitral Valve Repair Versus Replacement in Simultaneous Mitral and Aortic Valve Surgery for Rheumatic Disease Kenji Kuwaki, MD, PhD, Nobuyoshi Kawaharada,

Harm H. H. Feringa, MD, Leslee J

Jeffrey G. Gaca, MD, Shubin Sheng, PhD, Mani Daneshmand, MD, J

Reoperation After Mitral Valve Repair for Degenerative Disease

Mitral Valve Repair Is Durable in Patients With Rheumatoid Arthritis

Does Prior Coronary Bypass Surgery Present a Unique Risk for Reoperative Valve Surgery? Andrew Breglio, BS, Anelechi Anyanwu, MD, Shinobu Itagaki, MD,

Surgical Versus Medical Therapy for Prosthetic Valve Endocarditis: A Meta-Analysis of 32 Studies Christos G. Mihos, DO, Romain Capoulade, PhD, Evin Yucel,

Linetta B. Koppert, MD, PhD, Albertus N. van Geel, MD, PhD, Titia E

The Optimal Weaning Strategy for Intraaortic Balloon Counterpulsation: Volume-Based Versus Rate-Based Approach in an Animal Model Sandro Gelsomino, MD,

Outcomes of Early Mitral Valve Reoperation in the Medicare Population

Factors Affecting Survival After Mitral Valve Replacement in Patients With Prosthesis– Patient Mismatch Abdulhameed Aziz, MD, Jennifer S. Lawton, MD,

Right Isthmus Ablation Reduces Supraventricular Arrhythmias After Surgery for Chronic Atrial Fibrillation Francesco Onorati, MD, Antonio Esposito, MD,

Chordae Replacement Versus Resection for Repair of Isolated Posterior Mitral Leaflet Prolapse: À Ègalité Joerg Seeburger, MD, Volkmar Falk, MD, PhD,

Jeffery Shuhaiber, MD, Andrew Y. Shin, MD, Jeffrey G

Meta-Analysis of Peripheral or Central Extracorporeal Membrane Oxygenation in Postcardiotomy and Non-Postcardiotomy Shock Giuseppe Maria Raffa, MD, Mariusz.

Mitral valve operation in patients with the Marfan syndrome

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Mitral valve repair or replacement for ischemic mitral regurgitation

Minimally Invasive Fibrillating Heart Surgery: A Safe and Effective Approach for Mitral Valve and Surgical Ablation for Atrial Fibrillation Paul S. Massimiano,

Twenty-Year Experience With the CarboMedics Mechanical Valve Prosthesis Denis Bouchard, MD, Amine Mazine, MD, Louis-Mathieu Stevens, MD, Michel Pellerin,

Determinants of Left Ventricular Dysfunction After Repair of Chronic Asymptomatic Mitral Regurgitation Vincent Chan, MD, MPH, Marc Ruel, MD, MPH, Elsayed.

Long-Term Outcomes of Open Arch Repair After a Prior Aortic Operation: Our Experience in 154 Patients Roberto Di Bartolomeo, MD, Paolo Berretta, MD,

Tethering Symmetry Reflects Advanced Left Ventricular Mechanical Dyssynchrony in Patients With Ischemic Mitral Regurgitation Undergoing Restrictive Mitral.

John M. Stulak, MD, Joseph A. Dearani, MD, Harold M

Infective Endocarditis With Paravalvular Extension: 35-Year Experience

Postoperative Outcome of Isolated Tricuspid Valve Operation Using Arrested-Heart or Beating-Heart Technique Bettina Pfannmüller, MD, Piroze Davierwala,

Luca Roncati, MD, PhD, Antonio Manenti, MD, PhD

Jerry Braun, MD, Nico R. van de Veire, MD, Robert J. M

Long-Term Survival and Freedom From Reoperation After Placement of a Pulmonary Xenograft Valved Conduit George M. Alfieris, MD, Michael F. Swartz, PhD,

Aortic Root Replacement for Children With Loeys-Dietz Syndrome

James W.W. Wong, MD, Koon-Hou Mak, MD, FACC

Surgical Treatment of Aortic Prosthetic Valve Endocarditis: A 20-Year Single-Center Experience Sossio Perrotta, MD, Anders Jeppsson, MD, PhD, Victoria.

John M. Stulak, MD, Rakesh M. Suri, MD, DPhil, Joseph A

Very long-term results (up to 17 years) with the double-orifice mitral valve repair combined with ring annuloplasty for degenerative mitral regurgitation

Deterioration of a Tricuspid Bioprosthesis Due to Adhesion of the Native Valve Herbert Gutermann, MD, Willem Flameng, MD, PhD, Paul Herijgers, MD, PhD

The Unifocal Bilateral Bidirectional Cavopulmonary Anastomosis

What Is the Role of Minimally Invasive Mitral Valve Surgery in High-Risk Patients? A Meta-Analysis of Observational Studies Marco Moscarelli, MD, Khalil.

Sander Bramer, MD, Albert H. M. van Straten, MD, PhD, Mohamed A

Cost-Effectiveness of Mitral Valve Repair Versus Replacement by Biologic or Mechanical Prosthesis Ariel Beresniak, MD, PhD, Brigitte Sabatier, PharmD,

Left-Sided Reoperations After Arterial Switch Operation: A European Multicenter Study Vladimiro L. Vida, MD, PhD, Lorenza Zanotto, MD, Lucia Zanotto,

Mark Ruzmetov, MD, PhD, Dale M. Geiss, MD, Jitendra J

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

Patient-Prosthesis Mismatch After Mitral Valve Replacement: A Propensity Score Analysis Ho Young Hwang, MD, PhD, Yong Han Kim, MD, Kyung-Hwan Kim, MD,

Right Minithoracotomy Versus Full Sternotomy for Mitral Valve Repair: A Propensity Matched Comparison Rüdiger Lange, MD, PhD, Bernhard Voss, MD, Victoria.

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

Duke E. Cameron, MD, Diane E. Alejo, BA, Nishant D. Patel, BA, Lois U

John M. Stulak, MD, Harold M. Burkhart, MD, Joseph A

Cavernous Hemangioma of the Posterior Mediastinum

Is Surgery Always Mandatory for Type A Aortic Dissection?

Justin P. V. Zachariah, MD, Frank A. Pigula, MD, John E

The Impact of New Technology on Cardiothoracic Surgical Practice

Umar S. Boston, MD, Joseph A. Dearani, MD, Patrick W

Risk of Valve-Related Events After Aortic Valve Repair

Left Ventricular Reverse Remodeling After Undersized Mitral Ring Annuloplasty in Patients With Ischemic Regurgitation Sandro Gelsomino, MD, Roberto Lorusso,

Repair of Left Ventricular Inflow Tract Lesions in Shone's Anomaly: Valve Growth and Long-Term Outcome Eva Maria B. Delmo Walter, MD, PhD, Richard Van.

Presentation transcript:

Emergency Surgery for Native Mitral Valve Endocarditis: The Impact of Septic and Cardiogenic Shock Sandro Gelsomino, MD, PhD, Jos G. Maessen, MD, PhD, Frederik van der Veen, MD, PhD, Ugolino Livi, MD, Attilio Renzulli, MD, Fabiana Lucà, MD, Rocco Carella, MD, Elena Crudeli, MD, Antonio Rubino, MD, Carlo Rostagno, MD, Claudio Russo, MD, Valentino Borghetti, MD, Cesare Beghi, MD, Michele De Bonis, MD, PhD, Gian Franco Gensini, MD, Roberto Lorusso, MD, PhD The Annals of Thoracic Surgery Volume 93, Issue 5, Pages 1469-1476 (May 2012) DOI: 10.1016/j.athoracsur.2011.11.025 Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 (A) Overall 18-year actuarial survival (continuous line) and 95% confidence interval (dotted lines). (B) Actuarial survival by group: group 1 (diamonds), no shock; group 2 (triangles), cardiogenic shock; and group 3 (squares), septic shock. (C) Actuarial survival by surgical procedure: mitral valve (MV) repair (diamonds) versus replacement (triangles). The Annals of Thoracic Surgery 2012 93, 1469-1476DOI: (10.1016/j.athoracsur.2011.11.025) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 (A) Freedom from recurrent endocarditis (continuous line) and 95% confidence interval (dotted lines). (B) Freedom from recurrent endocarditis: group 1 (diamonds), no shock; group 2 (triangles), cardiogenic shock; and group 3 (squares), septic shock. (C) Freedom from recurrent endocarditis: mitral valve (MV) repair (diamonds) versus replacement (triangles). The Annals of Thoracic Surgery 2012 93, 1469-1476DOI: (10.1016/j.athoracsur.2011.11.025) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 (A) Freedom from reoperation (continuous line) and 95% confidence interval (dotted lines). (B) Freedom from reoperation: group 1 (diamonds), no shock; group 2 (triangles), cardiogenic shock; and group 3 (squares), septic shock. (C) Freedom from reoperation: mitral valve (MV) repair (diamonds) versus replacement (triangles). The Annals of Thoracic Surgery 2012 93, 1469-1476DOI: (10.1016/j.athoracsur.2011.11.025) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions